Skip to main navigation
Skip to search
Skip to main content
the University of Groningen research portal Home
Help & FAQ
English
Nederlands
Home
Profiles
Research units
Research output
Activities
Datasets
Press/Media
Projects
Prizes
Search by expertise, name or affiliation
Targeted induction of apoptosis for cancer therapy
Edwin Bremer
Research output
:
Thesis
›
Thesis fully internal (DIV)
2568
Downloads (Pure)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Targeted induction of apoptosis for cancer therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Acute Lymphoblastic Leukemia
5%
Antiapoptotic
5%
B Cell Lymphoma
5%
Binding Site
5%
Cancer Growth
5%
Carcinogenesis
5%
Carcinoma
11%
Cellular Organism
5%
Cetuximab
11%
Death Receptor
5%
Death Receptor 4
5%
Death Receptor 5
5%
Disease
5%
Elimination
5%
Epidermal Growth Factor Receptor
66%
Epidermal Growth Factor Receptor Kinase Inhibitor
5%
Epileptic Absence
16%
Epithelial Cell Adhesion Molecule
5%
Fusion Protein
44%
Gefitinib
22%
Glioblastoma
5%
Glycoprotein
83%
Immunotherapy
5%
Malignant Neoplasm
100%
Metastasis Potential
5%
Monoclonal Antibody
5%
Neoplasm
100%
Normal Human
5%
Protein Aggregate
5%
Protein Tyrosine Kinase Inhibitor
5%
Therapeutic Effect
5%
Tumor Necrosis Factor
5%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand Receptor
16%
Immunology and Microbiology
Antigen Expression
2%
B Cell
2%
Binding Site
2%
Bystander Effect
9%
Cancer Cell
20%
Cell Cycle Progression
2%
Cell Death
2%
Cell Growth
2%
Cell Line
6%
Cell Surface
9%
Cell Survival
2%
Cellular Organism
2%
Cetuximab
4%
Cross Linking
9%
Death Receptor
2%
Downregulation
2%
Epidermal Growth Factor
29%
Epithelial Cell Adhesion Molecule
2%
Glycoprotein
34%
Hemocyte
2%
Homeostasis
2%
Human Cell
2%
Immune Response
2%
Immunotherapy
2%
Malignant Progression
4%
Masking
2%
Mixed Cell Culture
4%
Molecular Weight
2%
Monoclonal Antibody
2%
Natural Killer Cell
2%
Normal Human
2%
Plasmid
2%
T Cell
11%
Target Cell
15%
TNF related apoptosis inducing ligand
100%
Tumor Cell
18%
Tumor Necrosis Factor
2%
Upregulation
2%
Biochemistry, Genetics and Molecular Biology
Antigen Expression
2%
B Cell
2%
Binding Site
2%
Bystander Effect
9%
Cancer Cell
20%
Carcinogenesis
2%
Cell Cycle Progression
2%
Cell Death
2%
Cell Growth
2%
Cell Survival
2%
Cellular Organism
2%
Cetuximab
4%
Cross-Link
9%
Downregulation
2%
Eicosanoid Receptor
2%
Epidermal Growth Factor Receptor
29%
Epithelial Cell Adhesion Molecule
2%
Fusion Protein
18%
Gefitinib
2%
Glycoprotein
34%
Hemocyte
2%
Homeostasis
2%
Immune Response
2%
Masking
2%
Mixed Cell Culture
4%
Molecular Weight
2%
Monoclonal Antibody
2%
Natural Killer Cell
2%
Normal Human
2%
Plasmid
2%
Receptor Tyrosine Kinase Inhibitors
2%
Small Molecule
2%
Surface Property
9%
T Cell
11%
Target Cell
15%
TRAIL
100%
Tumor Necrosis Factor
2%
Tyrosine Kinase Inhibitor
2%
Upregulation
2%
Keyphrases
Acute Lymphoblastic
3%
Antibody Fragment
3%
Anticancer Activity
3%
Antitumor
19%
Apoptotic Mechanism
3%
Bystander Cells
11%
C225
3%
Cancer Cell Growth
3%
Cellular Fate
3%
Cellular Homeostasis
3%
Cetuximab
3%
Effector Molecules
7%
Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor (EGFR-TKI)
3%
Eukaryotic Expression
3%
Expression Platform
3%
Fratricide
3%
Gefitinib
3%
Glioblastoma multiforme
3%
Inducing Ligand
7%
Industrial Grade
3%
Innocent Bystanders
3%
Intrinsic Signaling
3%
Iressa
7%
Malignant Progression
7%
Membrane-bound Form
3%
Metastatic Potential
3%
Mitogenic Signaling
7%
Passive Transfer
3%
Producer Cell Line
3%
Recombinant Form
3%
Recombinant Fusion Proteins
3%
Retroviral Transduction
3%
Robust Features
3%
Signaling Activity
7%
Small Molecule Tyrosine Kinase Inhibitors
3%
Soluble TRAIL
100%
T-cell Leukemia
3%
Targeted Tumor
3%
Therapeutic Value
3%
TNF Superfamily
3%
Tumor-associated
3%
Tumor-specific T Cells
3%
Virus-infected Cell
3%
ZD1839
3%